Non-RCRA vs. RCRA Hazardous Pharmaceutical Waste: What's the Difference?

Sam Spaccamonti
19 hours ago
10 min read

Quick Answer: RCRA pharmaceutical waste is medication waste that meets EPA hazardous waste criteria because it is P-listed, U-listed, or exhibits a hazardous characteristic such as ignitability, corrosivity, reactivity, or toxicity. Non-RCRA pharmaceutical waste does not meet these federal hazardous waste criteria, but it still requires proper disposal and may be subject to state-specific requirements. The classification determines how pharmaceutical waste must be stored, labeled, transported, documented, and disposed of.

What Is the Difference Between RCRA and Non-RCRA Pharmaceutical Waste?

The main difference is whether the pharmaceutical waste meets the EPA’s criteria for hazardous waste under RCRA. RCRA pharmaceutical waste is subject to federal hazardous waste requirements, while non-RCRA pharmaceutical waste does not meet those criteria but may still be regulated under state or other applicable requirements.

RCRA pharmaceutical waste is medication waste that meets specific EPA hazardous waste criteria. This may include pharmaceuticals that are P-listed or U-listed hazardous wastes or that exhibit characteristics such as ignitability, corrosivity, reactivity, or toxicity.

Non-RCRA pharmaceutical waste does not meet these federal RCRA hazardous waste criteria. However, that does not necessarily mean it can be disposed of as ordinary trash or poured down a drain. State regulations, facility policies, and other applicable requirements may determine how it must be handled and disposed of.

Feature	RCRA Pharmaceutical Waste	Non-RCRA Pharmaceutical Waste
Definition	Meets EPA hazardous waste criteria	Does not meet federal RCRA hazardous waste criteria
Classification	P-listed, U-listed, or exhibits a hazardous characteristic	Does not meet P/U-listing or characteristic criteria
Storage & Labeling	Requires RCRA-compliant containers, labeling, and accumulation requirements	Requirements depend on applicable state and facility rules
Transportation	Subject to applicable hazardous waste transportation and manifest requirements	Requirements vary depending on waste type and state regulations
Disposal	Must go through an appropriate permitted hazardous waste management pathway	Disposal pathway depends on applicable federal, state, and facility requirements
State Requirements	States may impose stricter requirements	State requirements can significantly affect management and disposal
Example	P-listed or U-listed pharmaceutical waste; waste exhibiting toxicity	Pharmaceutical waste that does not meet RCRA listing or characteristic criteria

What Is RCRA?

RCRA (Resource Conservation and Recovery Act) is the primary federal law governing the management of solid and hazardous waste in the United States. The EPA administers RCRA and establishes requirements for hazardous waste from generation through final disposal.

RCRA was enacted in 1976 and is codified under 42 U.S.C. §6901 et seq. It establishes a framework for managing hazardous waste from the point of generation through treatment, storage, transportation, and final disposal. While RCRA provides the federal framework, individual states may have additional or more stringent hazardous waste requirements.

For healthcare facilities, pharmaceutical waste is addressed under 40 CFR Part 266, Subpart P, which provides a specialized framework for managing hazardous pharmaceutical waste. The EPA's 2019 Hazardous Waste Pharmaceuticals Rule established these requirements specifically for healthcare facilities, including requirements related to pharmaceutical waste management and the prohibition on sewering hazardous pharmaceutical waste.

What Makes Pharmaceutical Waste RCRA Hazardous?

Pharmaceutical waste is considered RCRA hazardous when it meets one of EPA’s hazardous-waste criteria: it is P-listed, U-listed, or exhibits one of the four hazardous characteristics.

1. P-Listed Hazardous Pharmaceutical Waste covers acutely toxic pharmaceuticals. These are drugs whose sole active ingredient appears on the EPA's P-list. The critical qualifier is "sole active ingredient." A drug with multiple active ingredients, of which only one is P-listed, does not automatically become P-listed waste. The listed chemical must be the only active pharmaceutical ingredient in the product. P-listed waste is classified as acutely hazardous, and even small quantities, as little as one kilogram per month, trigger large quantity generator standards. Additionally, when a P-listed drug is discarded, even the rinsed container that held it must be managed as hazardous waste.

Examples include: warfarin at concentrations greater than 0.3 percent (waste code P001), nicotine in non-FDA-approved forms (P075), physostigmine salicylate (P188), arsenic trioxide used in some cancer therapies (P012), and epinephrine (P042).

2. U-Listed Hazardous Pharmaceutical Waste covers discarded commercial chemical products on the EPA's U-list. Like P-listed waste, U-listed waste applies only when the listed chemical is the sole active ingredient. U-listed pharmaceuticals are classified as toxic hazardous waste, carrying less severe acute toxicity thresholds than P-listed materials but still subject to full RCRA hazardous waste management requirements.

Examples include: certain formulations of cyclophosphamide (U058), lindane used in pharmaceutical applications (U129), chlorambucil (U035), reserpine (U200), and saccharin and its salts (U202).

3. Characteristic Hazardous Pharmaceutical Waste A pharmaceutical that does not appear on the P-list or U-list can still be classified as RCRA hazardous waste if it exhibits one of four hazardous characteristics.

Ignitability applies to liquid pharmaceuticals with a flash point below 140 degrees Fahrenheit. Certain alcohol-based pharmaceutical preparations and some aerosol formulations may qualify as ignitable hazardous waste.

Corrosivity applies to pharmaceuticals with a pH of 2 or below, or 12.5 or above. Strongly acidic or alkaline pharmaceutical products fall into this category.

Reactivity applies to pharmaceuticals that are unstable under normal conditions, react violently with water, or generate toxic gases when exposed to water or other common substances.

Toxicity is evaluated using the Toxicity Characteristic Leaching Procedure, a standardized test that measures the concentration of specific contaminants that would leach from the waste if it were placed in a landfill.

Pharmaceuticals containing heavy metals such as selenium, barium, chromium, or mercury at concentrations above established thresholds are characteristic toxic hazardous wastes.

Some mineral supplements containing selenium or chromium at concentrations exceeding TCLP limits fall into this category even though they would not intuitively be considered hazardous drugs.

What Is Non-RCRA Pharmaceutical Waste?

Non-RCRA pharmaceutical waste is pharmaceutical waste that does not meet RCRA criteria for P-listed, U-listed, or characteristic hazardous waste. It makes up a significant portion of pharmaceutical waste generated in healthcare settings.

However, non-RCRA does not mean environmentally harmless or suitable for regular disposal. Improper disposal can allow pharmaceuticals to enter waterways and affect aquatic ecosystems. Disposal requirements may also vary by state, facility policy, and applicable regulations.

What Falls Into the Non-RCRA Category?

Non-RCRA pharmaceutical waste includes a broad range of common medications that lack the characteristics that trigger RCRA classification.

Most antibiotics
Antihypertensives
Statins
Proton pump inhibitors
Antihistamines
Antidepressants
Antidiabetic medications
Routine pain relievers
Vitamins and nutritional supplements that do not contain heavy metals above TCLP thresholds
Over-the-counter medications

Non-RCRA pharmaceutical waste also includes certain drugs that might initially seem like they should be hazardous. U- and P-listed drugs in which the listed chemical is not the sole active ingredient are non-RCRA waste, because the listing criteria require that the listed chemical be the only active ingredient.

A combination product that contains a P-listed ingredient alongside other active ingredients does not meet the P-list definition and falls into non-RCRA status, though it may be subject to other disposal considerations.

Are NIOSH Hazardous Drugs the Same as RCRA Hazardous Waste?

No. NIOSH hazardous drug classification and RCRA hazardous waste classification are separate systems with different purposes.

The NIOSH Hazardous Drug list, most recently updated in 2024, identifies drugs that pose occupational health risks to healthcare workers who handle them due to carcinogenicity, teratogenicity, reproductive toxicity, or other serious health effects at low exposure levels. Many chemotherapy agents and other antineoplastic drugs appear on the NIOSH list.

However, being on the NIOSH list does not automatically make a drug RCRA hazardous. A drug can require special handling under NIOSH guidelines and still be non-RCRA pharmaceutical waste if it does not meet the EPA's listing or characteristic criteria.

This creates a category that requires particular attention in healthcare settings: NIOSH hazardous drugs that are non-RCRA waste. These drugs require specific occupational safety precautions during handling and administration but follow non-RCRA disposal pathways. Trace chemotherapy waste from drugs that are not RCRA-listed falls into this category and is typically managed in purple containers destined for high-temperature incineration.

Key Differences in Disposal Requirements

The classification of pharmaceutical waste as RCRA or non-RCRA determines how it is stored, transported, documented, and disposed of.

1. Container Requirements

RCRA: Requires properly labeled hazardous-waste containers, including applicable waste codes.
Non-RCRA: Typically uses facility/vendor-designated pharmaceutical waste containers with appropriate labeling.
Mixing: RCRA and non-RCRA waste should be kept separate to avoid additional compliance and disposal requirements.

2. Storage Limitations

RCRA: Under 40 CFR Part 266 Subpart P, LQGs generally have 90 days, SQGs 270 days, and VSQGs 12 months for off-site management.
Non-RCRA: No federal RCRA accumulation limit, but state and facility requirements may apply.

3. Transportation & Manifesting

RCRA: Requires hazardous-waste manifesting and appropriate RCRA pharmaceutical waste codes.
Non-RCRA: Generally does not require a federal hazardous-waste manifest, though vendors may provide disposal records or certificates.

4. Disposal Methods

RCRA: Must go to an appropriately permitted facility; permitted high-temperature incineration is commonly used.
Non-RCRA: Has more disposal options, but requirements vary by state, and incineration is commonly used.

5. Penalties

RCRA: Violations can result in significant federal and state penalties, including civil and criminal enforcement.
Non-RCRA: Penalties primarily depend on applicable state and local requirements.

How to Determine Whether Pharmaceutical Waste Is RCRA or Non-RCRA

The classification process starts by checking whether the pharmaceutical waste meets federal RCRA hazardous waste criteria. Follow these steps to determine whether it should be managed as RCRA or non-RCRA pharmaceutical waste.

1. Check the EPA P-list and U-list: Determine whether the pharmaceutical or its active ingredient appears on the EPA’s P-list or U-list of hazardous wastes.

2. Confirm the active ingredient requirements: If the pharmaceutical is listed, check whether the listed chemical meets the applicable sole-active-ingredient criteria for that waste listing.

3. Evaluate the four hazardous waste characteristics: If the waste is not P- or U-listed, determine whether it exhibits any of these hazardous characteristics:

Ignitability
Corrosivity
Reactivity
Toxicity

4. Check applicable state requirements: Review the requirements of the state where the waste is generated. State hazardous waste programs may have requirements that are more stringent than federal RCRA requirements.

5. Verify the classification when uncertain: If the classification is unclear, follow the facility’s approved waste-determination process and consult current regulatory references or qualified environmental/compliance professionals before selecting a disposal method.

Quick Reference: RCRA vs. Non-RCRA Pharmaceutical Waste

Check	What It Means
P-listed or U-listed under applicable criteria	RCRA hazardous waste
Exhibits an applicable hazardous characteristic	RCRA hazardous waste
Does not meet RCRA listing or characteristic criteria	Non-RCRA under federal RCRA
NIOSH hazardous drug	Not automatically RCRA hazardous
State requirements	Always verify separately
Hazardous pharmaceutical waste	Do not dispose of down the drain

How Do DEA Controlled Substances Interact With RCRA Pharmaceutical Waste Rules?

Some pharmaceutical waste may be both RCRA hazardous waste and a DEA-controlled substance, requiring compliance with both regulatory frameworks. Under the 2019 Hazardous Waste Pharmaceuticals Rule, certain controlled substances may qualify for a conditional RCRA exemption when disposed of according to DEA requirements. However, the sewer prohibition still applies, so these substances cannot be flushed.

Facilities should use disposal processes and vendors that properly address both DEA requirements, including chain of custody and witnessed destruction, and applicable RCRA requirements.

How to Build a Compliant Pharmaceutical Waste Classification Program

Effective classification starts at the point of waste generation. Facilities should maintain an up-to-date pharmaceutical inventory cross-referenced with EPA's P-list, U-list, and hazardous waste characteristics.

Staff should be trained to identify the correct waste stream and know what to do when classification is unclear. When in doubt, facilities should confirm the classification before disposal and follow the more protective applicable requirements to reduce compliance risks.

Need Pharmaceutical Waste Pickup in San Diego?

SD Med Waste provides compliant, reliable pharmaceutical waste disposal for healthcare facilities throughout San Diego County.

Get a Free Quote →

Get a FREE Quote →

Frequently Asked Questions (FAQs)

Q1: What is the simplest way to determine whether a pharmaceutical waste is RCRA hazardous or non-RCRA?

The determination follows a two-step process. First, check whether the drug's sole active ingredient appears on the EPA's P-list or U-list. If it does, and if the listed chemical is the only active ingredient, the waste is RCRA hazardous regardless of quantity or other characteristics.

Second, if the drug is not listed, evaluate whether it exhibits any of the four RCRA hazardous characteristics: ignitability, corrosivity, reactivity, or toxicity as measured by the Toxicity Characteristic Leaching Procedure. If it exhibits none of these characteristics and does not appear on the P or U list, it is non-RCRA pharmaceutical waste.

Many licensed pharmaceutical waste vendors provide formulary review services and drug lookup tools that help facilities make this determination accurately for every drug in their inventory.

Q2: Does non-RCRA pharmaceutical waste still need to be disposed of by a licensed vendor, or can it go in regular trash?

Non-RCRA pharmaceutical waste cannot simply be placed in regular trash or flushed down a drain, despite the designation "non-hazardous." State regulations in most jurisdictions prohibit the disposal of pharmaceutical waste in municipal solid waste streams, and the EPA strongly recommends incineration for all pharmaceutical waste to prevent active pharmaceutical ingredients from entering waterways and soil.

The correct disposal pathway for non-RCRA pharmaceutical waste is collection in clearly labeled pharmaceutical waste containers, pickup by a licensed medical waste or pharmaceutical waste vendor, and disposal through incineration at an appropriate facility. Facilities should confirm the specific requirements applicable in their state, as state-level rules for non-RCRA pharmaceutical waste vary considerably.

Q3: What happens if RCRA hazardous pharmaceutical waste and non-RCRA pharmaceutical waste are mixed in the same container?

When a container holds any combination of RCRA hazardous and non-RCRA pharmaceutical waste, the entire contents of that container must be managed as RCRA hazardous waste. This is sometimes referred to as the "mixture rule" under RCRA. The practical consequence is a significant increase in disposal cost and regulatory burden for what may be a largely non-hazardous load.

It also means that a single misclassified item placed in a non-RCRA container can require reclassification of the entire container's contents. This is one of the primary reasons that effective staff training and clearly labeled, purpose-specific containers at every point of waste generation are essential components of a compliant pharmaceutical waste program.

Q4: Are NIOSH hazardous drugs the same as RCRA hazardous pharmaceutical waste?

No, and this is a critically important distinction for healthcare facilities. The NIOSH Hazardous Drug list identifies drugs that pose occupational health risks to healthcare workers who handle them, including carcinogens, teratogens, and drugs with reproductive toxicity or other serious health effects. Many antineoplastic and chemotherapy drugs appear on the NIOSH list. However, being on the NIOSH list does not automatically make a drug RCRA hazardous waste.

A NIOSH hazardous drug is only RCRA hazardous waste if it independently meets the EPA's listing or characteristic criteria: it must appear on the P-list or U-list as the sole active ingredient, or it must exhibit ignitability, corrosivity, reactivity, or TCLP toxicity.

Many NIOSH hazardous drugs are non-RCRA pharmaceutical waste and are managed in purple trace chemotherapy containers for incineration rather than in black RCRA hazardous waste containers. Facilities must apply both the NIOSH occupational safety framework and the RCRA hazardous waste classification framework independently and simultaneously for antineoplastic and other hazardous drug waste.

Q5: What was the significance of the EPA's 2019 Hazardous Waste Pharmaceuticals Rule for healthcare facilities?

The 2019 rule, effective August 21, 2019, was the most significant development in pharmaceutical hazardous waste regulation for healthcare settings since RCRA was enacted. Before the rule, healthcare facilities managed their hazardous waste pharmaceuticals under the general RCRA hazardous waste generator standards, which created compliance challenges because those standards were designed for industrial generators rather than clinical settings.

The 2019 rule created a tailored, healthcare-specific framework under 40 CFR Part 266 Subpart P that replaced general generator standards for covered facilities with sector-specific requirements that better fit clinical operations. Importantly, the rule imposed a universal sewer prohibition, prohibiting all healthcare facilities regardless of generator size from flushing hazardous waste pharmaceuticals down the drain.

This prohibition took effect nationwide in August 2019 and is credited by the EPA with reducing hazardous pharmaceutical compounds entering waterways by an estimated 1,644 to 2,300 tons annually. The rule was updated with technical corrections in December 2024 and further amendments in early 2025.